Pancreatic Cancer Research

ResearcherUniversity of California, Los AngelesNo recent work listed

Guisheng Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1295-1917; OpenAlex author ID A5026705969. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: none · 2014: 1 paper · 2015: none · 2016: 1 paper

Papers 4

  1. Metformin Restrains Pancreatic Duodenal Homeobox-1 (PDX-1) Function by Inhibiting ERK Signaling in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.2174/1566524016666151222145551↗
  2. Vertically integrated translational studies of PDX1 as a therapeutic target for pancreatic cancer via a novel bifunctional RNAi platform. Co-author DOI 10.1038/cgt.2013.84↗
  3. PDX-1 is a therapeutic target for pancreatic cancer, insulinoma and islet neoplasia using a novel RNA interference platform. Co-author DOI 10.1371/journal.pone.0040452↗
  4. PDX-1: demonstration of oncogenic properties in pancreatic cancer. Co-author DOI 10.1002/cncr.25629↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. John J. Nemunaitis · 4 shared papers, 2011–2016 · strength 0.14
  2. Francis Charles Brunicardi · 4 shared papers, 2011–2016 · strength 0.14
  3. James X. Wu · 2 shared papers, 2014–2016 · strength 0.09
  4. Donald Rao · 2 shared papers, 2012–2014 · strength 0.06
  5. James W. Sinnett‐Smith · 1 shared paper, 2016 · strength 0.05
  6. Enrique Rozengurt · 1 shared paper, 2016 · strength 0.05
  7. Shi‐He Liu · 2 shared papers, 2011–2012 · strength 0.05
  8. Marie‐Claude Gingras · 2 shared papers, 2011–2012 · strength 0.05
  9. Min Li · 1 shared paper, 2011 · strength 0.03
  10. Changyi Chen · 1 shared paper, 2011 · strength 0.03
  11. William E. Fisher · 1 shared paper, 2012 · strength 0.03
  12. David W. Dawson · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.